Amphastar Pharmaceuticals Inc Income Statement - Real Clear Investing

Selected Year:

31-Dec
2020

Gross receipts in the form of cash (great!) and promises to pay (Account Receivables - not so great as some of them will never be collected but reality of business!) from all its customers

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Total Revenue	45,679	45,679	45,679	45,679	45,679	240,175	294,666	322,357	349,846	349,846	383,684

Selected Year:

31-Dec
2020

Cost (labor, materials, depreciation, overhead, etc) for delivering service or manufacturing a product that business sells

96.9%

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Cost of revenue	45,679	45,679	45,679	45,679	45,679	149,666	187,681	190,434	206,506	206,506	236,356
Gross profit	45,679	45,679	45,679	45,679	45,679	90,509	106,985	131,923	143,340	143,340	147,328
Research and development	45,679	45,679	45,679	45,679	45,679	43,503	57,564	68,853	67,229	67,229	72,532
Selling distribution and marketing	45,679	45,679	45,679	45,679	45,679	6,460	8,156	12,830	14,780	14,780	15,148
General and administrative	45,679	45,679	45,679	45,679	45,679	44,458	49,888	50,279	50,377	50,377	48,132
Gain or loss on sale of intangible assets	-	-	-	45,679	45,679	(2,643)	-	-	-	-	-
Impairment of long-lived assets	45,679	45,679	-	-	-	-	-	-	-	-	-
Total operating expenses	45,679	45,679	45,679	45,679	45,679	$91,778	$115,608	$131,962	$132,386	$132,386	$135,812

Selected Year:

31-Dec
2020

Income after excluding Operating Expenses from Total Revenue

3.1%

Key metric that shows earnings potential of the company's business model

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Operating income	$45,679	$45,679	$45,679	$45,679	$45,679	($1,269)	($8,623)	($39)	$10,954	$10,954	$11,516

Selected Year:

31-Dec
2020

Cost usually unrelated to delivering service or manufacturing a product that business sells

1.8%

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year:	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Other expense or income	-	45,679	45,679	45,679	45,679	2,919	(1,516)	59,389	(6,585)	(6,585)	(38,652)
Other income	45,679	-	-	-	-	-	-	-	-	-	-
Total non-operating income (expense)	45,679	45,679	45,679	45,679	45,679	2,518	(1,303)	60,267	(6,317)	(6,317)	(38,484)

Selected Year:

31-Dec
2020

Income after excluding Operating and Non-operating Expenses from Total Revenue

1.2%

Another income metric but unlike Operating Income it is closer to the ultimate income metric - Net Income by removing expenses that are not related to earning Revenue as they are supposed to be accidental and transitory

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
EBIT	$45,679	$45,679	$45,679	$45,679	$45,679	$1,650	($10,139)	$59,350	$4,369	$4,369	($27,136)

Selected Year:

31-Dec
2020

Expenses driven mostly by company management's choices, nature of business (capital intensive vs not) about financing (debt vs equity) and legal structure

0.9%

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Interest expense	45,679	45,679	45,679	45,679	45,679	(826)	(243)	(119)	(374)	(374)	(352)
Interest income	45,679	45,679	45,679	45,679	45,679	425	456	997	642	642	520
Income before income taxes	45,679	45,679	45,679	45,679	45,679	1,249	(9,926)	60,228	4,637	4,637	(26,968)
Income tax expense or benefit	45,679	45,679	45,679	45,679	45,679	(2,398)	(3,266)	13,723	3,540	3,540	(3,800)

Selected Year:

31-Dec
2020

Ultimate measure of Income - Net result after excluding all expenses from Total Revenue

0.3%

It is a residue that is left from Total Revenue after paying all kind of expenses and belongs to all equity holders in the company. Some of these shareholders such Non-controlling interest or Preferred equity gets their share before Common shareholders

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Net income (loss)	$45,679	$45,679	$45,679	$45,679	$45,679	$3,647	($6,660)	$46,505	$1,097	$1,097	($23,168)
Net income (loss) attributable to non-controlling interests Net income (loss) attributable to non-controlling interests	-	-	-	-	45,679	-	(922)	(2,434)	(306)	(306)	1,924
Net income (loss) attributable to Company	-	-	-	-	45,679	3,647	(5,738)	48,939	1,403	1,403	(25,092)

Basic shares outstanding as of certain dates reported by Company on its annual and quarterly filings, these numbers are NOT used calculation of basic EPS. They help to see share issuance by company in perspective

	2012 31-Dec	2013 31-Dec	2015 18-Mar	2016 08-Mar	2017 08-Mar	2018 06-Mar	2019 08-Mar	2020 09-Mar	2021 08-Mar	2021 08-Mar	2021 08-Mar
Common	-	-	45,678,795	45,678,795	45,678,795	46,350,595	46,788,811	46,238,303	47,432,937	47,432,937	47,432,937

Selected Year:

31-Dec
2020

Net Income / Shares Outstanding = EPS before dilution or Basic EPS; Net Income/ ( Shares Outstanding + potentially available shares from conversion of various option instruments)

	2012 31-Dec	2013 31-Dec	2014 31-Dec	2015 31-Dec	2016 31-Dec	2017 31-Dec	2018 31-Dec	2019 31-Dec	Selected Year: 2020 31-Dec	Last Twelve Months LTM 2020 31-Dec	Last Quarter Annualized LQA 2020 31-Dec
Net Income per basic share	$45,678,795.00	$45,678,795.00	$45,678,795.00	$45,678,795.00	$45,678,795.00	$0.08	($0.12)	$1.04	$0.03	$0.03	($0.52)
Net Income per diluted share	$45,678,795.00	$45,678,795.00	$45,678,795.00	$45,678,795.00	$45,678,795.00	$0.08	($0.12)	$0.98	$0.03	$0.03	($0.52)

Amphastar Pharmaceuticals Inc

Short Description

Income Statement

Cost of revenue

Research and development

General and administrative

Selling distribution and marketing

Operating Income

Other expense or income

EBIT

Interest income

Interest expense

Income tax expense or benefit

Net income (loss)